Deep Dive

Market Access

Is it time to rethink electronic prescribing in the US?

It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime.

Market Access

Combination pricing: access to the future of oncology treatm...

Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.

Market Access

Closing the digital expectation gap in pharma

Jan Deman is Takeda’s head of digital customer experience for Europe and Canada. But he’d prefer not to refer to what he does as “innovation”.

Market Access

How do we make patient centricity a reality?

For years, the subject of fostering direct connections with patients has been highlighted by notable figures across the healthcare and life sciences industries as a key feature to be explor

Market Access

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in a specific t

Market Access